⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrahydrofuran SCHEMBL16738662 | 0.97 | ALDH1A1 (0.53) | — | |
| Isopropyl Alcohol SCHEMBL9004332 | 0.97 | ALDH1A1 (0.53) | — | |
| Tetrahydrofuran SCHEMBL2143001 | 0.97 | ALDH1A1 (0.53) | — | |
| Tetrahydrofuran SCHEMBL635322 | 0.91 | ALDH1A1 (0.47) | — | |
| Tetrahydrofuran SCHEMBL28299228 | 0.88 | ALDH1A1 (0.44) | — | |
| Tetrahydrofuran SCHEMBL10386650 | 0.88 | ALDH1A1 (0.44) | — | |
| Tetrahydrofuran SCHEMBL27823038 | 0.87 | ALDH1A1 (0.50) | — | |
| Tetrahydrofuran SCHEMBL23455755 | 0.86 | ALDH1A1 (0.42) | — | |
| Dioxane SCHEMBL28294558 | 0.86 | ALDH1A1 (0.42) | — | |
| Tetrahydrofuran SCHEMBL11521890 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 296 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4400097-A1 | LONG-ACTING BREXPIPRAZOLE PREPARATION FOR INJECTION AND PREPARATION METHOD THEREFOR | Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. (CN) | 2024-07-17 | — | — | EP | claimed |
| CN-117794517-A | Bulleprazole long-acting preparation for injection and preparation method thereof | 四川科伦药物研究院有限公司 | 2024-03-29 | — | — | CN | claimed |
| EP-3133061-B1 | FLORFENICOL SYNTHESIZING METHOD | MASTEAM BIO TECH CO LTD (CN) | 2024-03-20 | — | — | EP | claimed |
| WO-2024003428-A1 | QUINONE-DERIVED COMPOUNDS AND USE THEREOF AGAINST LEISHMANIA SPP | UNIVERSIDAD DE LA LAGUNA (ES) | 2024-01-04 | — | — | WO | claimed |
| WO-2023036003-A1 | LONG-ACTING BREXPIPRAZOLE PREPARATION FOR INJECTION AND PREPARATION METHOD THEREFOR | 四川科伦药物研究院有限公司 | 2023-03-16 | — | — | WO | claimed |
| CN-115777906-A | Sodium chloride nano-micron particle and preparation method and application thereof | 吉林大学 | 2023-03-14 | — | — | CN | claimed |
| CN-113072482-A | Preparation method of repaglinide deuterium-labeled metabolite | 梯尔希（南京）药物研发有限公司 | 2021-07-06 | — | — | CN | claimed |
| US-20210188856-A1 | CRYSTAL FORM OF HYDROCHLORIDE OF PYRAZOLOHETEROARYL DERIVATIVE AND PREPARATION METHOD | SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD (CN) | 2021-06-24 | — | — | US | claimed |
| CN-112691236-A | Bionic Janus type chitin nanofiber membrane and preparation method thereof | 无锡中科光远生物材料有限公司 | 2021-04-23 | — | — | CN | claimed |
| EP-3808745-A1 | CRYSTAL FORM OF HYDROCHLORIDE OF PYRAZOLOHETEROARYL DERIVATIVE AND PREPARATION METHOD | Jiangsu Hengrui Medicine Co., Ltd. (CN) | 2021-04-21 | — | — | EP | claimed |
| CN-111819178-A | Crystal form of pyrazolo heteroaryl derivative hydrochloride and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2020-10-23 | — | — | CN | claimed |
| CN-111122802-A | Method for measuring release curve of propofol fat emulsion injection | 广东嘉博制药有限公司 | 2020-05-08 | — | — | CN | claimed |
| CN-108929363-A | A kind of preparation method of anticancer drug lanosterol derivative | 东莞中山大学研究院 | 2018-12-04 | — | — | CN | claimed |
| CN-108254450-A | In Propofol/detection method of long chain fat emulsion injection envelop rate | 上海医药集团股份有限公司 | 2018-07-06 | — | — | CN | claimed |
| EP-3133061-A1 | FLORFENICOL SYNTHESIZING METHOD | Masteam Bio-tech Co. Ltd. (CN) | 2017-02-22 | — | — | EP | claimed |
| US-20160318859-A1 | FLORFENICOL SYNTHESIZING METHOD | MASTEAM BIO-TECH CO. LTD. | 2016-11-03 | — | — | US | claimed |
| WO-2015117158-A1 | SYNTHETIC PLATELETS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-08-06 | — | — | WO | claimed |
| EP-1409766-A1 | SYSTEMS AND METHODS FOR DELIVERING AN ULTRAPURE CHEMICAL | L'Air Liquide S. A. à Directoire et Conseil de Surveillance pour l'Etude et l'Exploitation des Procédés Georges Claude (FR) | 2004-04-21 | — | — | EP | claimed |
| WO-2003012163-A2 | INTEGRAL BLOCKS, CHEMICAL DELIVERY SYSTEMS AND METHODS FOR DELIVERING AN ULTRAPURE CHEMICAL | L'AIR LIQUIDE-SOCIETE ANONYME A DIRECTOIRE ET CONSEIL DE SURVEILLANCE POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (US) | 2003-02-13 | — | — | WO | claimed |
| EP-4400097-A1 | LONG-ACTING BREXPIPRAZOLE PREPARATION FOR INJECTION AND PREPARATION METHOD THEREFOR | Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. (CN) | 2024-07-17 | — | — | EP | disclosed |
| WO-2024108094-A1 | LYOPHILIZATION BUFFERS FOR PEPTIDE-DECORATED LIPOSOMES | HAIMA THERAPEUTICS, LLC (US) | 2024-05-23 | — | — | WO | disclosed |
| CN-117949568-A | Method for separating free medicine in medicine micelle solution by taking HS-15 as solubilizer and measuring encapsulation rate | 江苏诺和必拓新药研发有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-117794517-A | Bulleprazole long-acting preparation for injection and preparation method thereof | 四川科伦药物研究院有限公司 | 2024-03-29 | — | — | CN | disclosed |
| EP-3133061-B1 | FLORFENICOL SYNTHESIZING METHOD | MASTEAM BIO TECH CO LTD (CN) | 2024-03-20 | — | — | EP | disclosed |
| WO-2024003428-A1 | QUINONE-DERIVED COMPOUNDS AND USE THEREOF AGAINST LEISHMANIA SPP | UNIVERSIDAD DE LA LAGUNA (ES) | 2024-01-04 | — | — | WO | disclosed |
| CN-116836067-A | Method for preparing diaminodiphenyl ether by continuous catalytic hydrogenation | 湖南贝泓科技开发有限公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-116554041-A | Method for preparing diaminodiphenyl ether by continuous catalytic hydrogenation based on trickle bed reactor | 湖南贝泓科技开发有限公司 | 2023-08-08 | — | — | CN | disclosed |
| CN-113933402-B | Method for separating and measuring betamethasone | 重庆华邦制药有限公司 | 2023-07-18 | — | — | CN | disclosed |
| CN-116283633-A | Crystal form of lysine acetate and preparation method thereof | 宜昌三峡普诺丁生物制药有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-113514573-B | Method for detecting content of span 60 | 澳美制药(苏州)有限公司 | 2023-06-06 | — | — | CN | disclosed |
| CN-114137091-B | Method for separating and detecting betamethasone sodium phosphate and/or related impurities | 重庆华邦胜凯制药有限公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-110678441-B | Novel synthesis for preparing dibenzoate compounds such as 4- [ benzoyl (methyl) amino ] pentane-2-yl dibenzoate | SABIC环球技术有限责任公司 | 2023-03-31 | — | — | CN | disclosed |
| WO-2023036003-A1 | LONG-ACTING BREXPIPRAZOLE PREPARATION FOR INJECTION AND PREPARATION METHOD THEREFOR | 四川科伦药物研究院有限公司 | 2023-03-16 | — | — | WO | disclosed |
| CN-115777906-A | Sodium chloride nano-micron particle and preparation method and application thereof | 吉林大学 | 2023-03-14 | — | — | CN | disclosed |
| US-20230039886-A1 | METHOD FOR SYNTHESIZING URSODEOXYCHOLIC ACID USING BA AS RAW MATERIAL | JIANGSU JIAERKE PHARMACEUTICALS GROUP CORP., LTD. (CN) | 2023-02-09 | — | — | US | disclosed |
| CN-114787146-A | Diacylglycerol acyltransferase 2 inhibitors | 辉瑞大药厂 | 2022-07-22 | — | — | CN | disclosed |
| US-11384012-B2 | Atomized anti-scratching nano-coating for glass surface and method of manufacturing thereof | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2022-07-12 | — | — | US | disclosed |
| CN-111819178-B | Crystal form of pyrazolo heteroaryl derivative hydrochloride and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-114137091-A | Method for separating and detecting betamethasone sodium phosphate and/or related impurities | 重庆华邦胜凯制药有限公司 | 2022-03-04 | — | — | CN | disclosed |
| CN-113933402-A | Method for separating and measuring betamethasone | 重庆华邦制药有限公司 | 2022-01-14 | — | — | CN | disclosed |
| CN-113514573-A | Method for detecting content of span 60 | 澳美制药(苏州)有限公司 | 2021-10-19 | — | — | CN | disclosed |
| EP-3890751-A1 | HIGHLY ACTIVE DRUG COMBINATION FOR TREATMENT OF HEPATITIS C VIRUS | ATEA Pharmaceuticals, Inc. (US) | 2021-10-13 | — | — | EP | disclosed |
| EP-3697755-B1 | NOVEL SYNTHESIS METHOD FOR THE PREPARATION OF DIBENZOATE COMPOUNDS, SUCH AS 4-[BENZOYL(METHYL)AMINO]PENTANE-2-YL DIBENZOATE | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2021-09-15 | — | — | EP | disclosed |
| US-11065249-B2 | Diacylglycerol acyl transferase 2 inhibitor | PFIZER INC. (US) | 2021-07-20 | — | — | US | disclosed |
| US-20210188856-A1 | CRYSTAL FORM OF HYDROCHLORIDE OF PYRAZOLOHETEROARYL DERIVATIVE AND PREPARATION METHOD | SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD (CN) | 2021-06-24 | — | — | US | disclosed |
| US-11034678-B2 | Diacylglycerol acyl transferase 2 inhibitors | PFIZER INC. (US) | 2021-06-15 | — | — | US | disclosed |
| CN-112691236-A | Bionic Janus type chitin nanofiber membrane and preparation method thereof | 无锡中科光远生物材料有限公司 | 2021-04-23 | — | — | CN | disclosed |
| EP-3808745-A1 | CRYSTAL FORM OF HYDROCHLORIDE OF PYRAZOLOHETEROARYL DERIVATIVE AND PREPARATION METHOD | Jiangsu Hengrui Medicine Co., Ltd. (CN) | 2021-04-21 | — | — | EP | disclosed |
| CN-107690433-B | Heteroaryl derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating PI3 kinase-associated diseases comprising the same as active ingredient | 韩国化学研究院 | 2021-04-09 | — | — | CN | disclosed |
| US-20210101828-A1 | ATOMIZED ANTI-SCRATCHING NANO-COATING FOR GLASS SURFACE AND METHOD OF MANUFACTURING THEREOF | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2021-04-08 | — | — | US | disclosed |
| WO-2021054013-A1 | MOLDING COMPOSITION AND MOLDED BODY | 王子ホールディングス株式会社 | 2021-03-25 | — | — | WO | disclosed |
| US-20210008223-A1 | SYNTHETIC PLATELETS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2021-01-14 | — | — | US | disclosed |
| CN-111819178-A | Crystal form of pyrazolo heteroaryl derivative hydrochloride and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2020-10-23 | — | — | CN | disclosed |
| US-10766854-B2 | Synthesis method for the preparation of dibenzoate compounds, such as 4-[benzoyl(methyl)amino]pentane-2-yl dibenzoate | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2020-09-08 | — | — | US | disclosed |
| EP-3697755-A1 | NOVEL SYNTHESIS METHOD FOR THE PREPARATION OF DIBENZOATE COMPOUNDS, SUCH AS 4-[BENZOYL(METHYL)AMINO]PENTANE-2-YL DIBENZOATE | SABIC Global Technologies B.V. (NL) | 2020-08-26 | — | — | EP | disclosed |
| US-20200239407-A1 | NOVEL SYNTHESIS METHOD FOR THE PREPARATION OF DIBENZOATE COMPOUNDS, SUCH AS 4-[BENZOYL(METHYL)AMINO]PENTANE-2-YL DIBENZOATE | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2020-07-30 | — | — | US | disclosed |
| EP-3312175-B1 | HETEROARYL DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH PI3 KINASES, CONTAINING SAME AS ACTIVE INGREDIENT | KOREA RES INST CHEMICAL TECH (KR) | 2020-07-22 | — | — | EP | disclosed |
| WO-2020117966-A1 | HIGHLY ACTIVE DRUG COMBINATION FOR TREATMENT OF HEPATITIS C VIRUS | Atea Pharmaceuticals, Inc. (US) | 2020-06-11 | — | — | WO | disclosed |
| US-20200181127-A1 | DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS | PFIZER INC. (US) | 2020-06-11 | — | — | US | disclosed |
| CN-111122802-A | Method for measuring release curve of propofol fat emulsion injection | 广东嘉博制药有限公司 | 2020-05-08 | — | — | CN | disclosed |
| CN-110791321-A | Coal tar hydrogenation scale inhibitor and preparation method thereof | 浙江杭化科技股份有限公司 | 2020-02-14 | — | — | CN | disclosed |
| CN-110678441-A | Novel synthesis for preparing dibenzoate compounds such as 4- [ benzoyl (methyl) amino ] pentane-2-yl dibenzoate | SABIC环球技术有限责任公司 | 2020-01-10 | — | — | CN | disclosed |
| US-10434149-B2 | Synthetic platelets | CASE WESTERN RESERVE UNIVERSITY (US) | 2019-10-08 | — | — | US | disclosed |
| CN-110014720-A | Ink film, which is formed, uses master, pattern forming method, pattern film forming method and pattern membrane formation device | 柯尼卡美能达株式会社 | 2019-07-16 | — | — | CN | disclosed |
| WO-2019077104-A1 | NOVEL SYNTHESIS METHOD FOR THE PREPARATION OF DIBENZOATE COMPOUNDS, SUCH AS 4-[BENZOYL(METHYL)AMINO]PENTANE-2-YL DIBENZOATE | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2019-04-25 | — | — | WO | disclosed |
| CN-108929363-A | A kind of preparation method of anticancer drug lanosterol derivative | 东莞中山大学研究院 | 2018-12-04 | — | — | CN | disclosed |
| US-20180311378-A1 | SYNTHETIC PLATELETS | NATIONAL SCIENCE FOUNDATION | 2018-11-01 | — | — | US | disclosed |
| EP-3020720-B1 | PHOSPHONATE ESTER DERIVATIVES AND METHODS OF SYNTHESIS THEREOF | CHIMERIX INC (US) | 2018-09-19 | — | — | EP | disclosed |
| US-10071992-B2 | Diacylglycerol acyl transferase 2 inhibitors | PFIZER INC. (US) | 2018-09-11 | — | — | US | disclosed |
| CN-108475771-A | Electrode for energy storage device | 日产化学工业株式会社 | 2018-08-31 | — | — | CN | disclosed |
| CN-108431995-A | Electrode for energy storage device | 日产化学工业株式会社 | 2018-08-21 | — | — | CN | disclosed |
| WO-2018144640-A1 | NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS | Atea Pharmaceuticals, Inc. (US) | 2018-08-09 | — | — | WO | disclosed |
| EP-2213707-B1 | INK COMPOSITION | SEIKO EPSON CORP (JP) | 2018-07-18 | — | — | EP | disclosed |
| CN-108254450-A | In Propofol/detection method of long chain fat emulsion injection envelop rate | 上海医药集团股份有限公司 | 2018-07-06 | — | — | CN | disclosed |
| EP-3312175-A1 | HETEROARYL DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH PI3 KINASES, CONTAINING SAME AS ACTIVE INGREDIENT | Korea Research Institute of Chemical Technology (KR) | 2018-04-25 | — | — | EP | disclosed |
| US-9951000-B2 | Florfenicol synthesizing method | MASTEAM BIO TECH CO LTD (CN) | 2018-04-24 | — | — | US | disclosed |
| US-20180105527-A1 | HETEROARYL DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSTION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH PI3 KINASES, CONTAINING SAME AS ACTIVE INGREDIENT | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2018-04-19 | — | — | US | disclosed |
| CN-107922379-A | Substituted guanidine derivatives | 宇部兴产株式会社 | 2018-04-17 | — | — | CN | disclosed |
| CN-104968495-B | Electronic device | 株式会社可乐丽 | 2018-04-10 | — | — | CN | disclosed |
| US-20180071368-A1 | SYNTHETIC PLATELETS | CASE WESTERN RESERVE UNIVERISTY | 2018-03-15 | — | — | US | disclosed |
| US-20180051012-A1 | DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS | PFIZER INC. (US) | 2018-02-22 | — | — | US | disclosed |
| CN-105026150-B | Multilayer structure making and its manufacture method | 株式会社可乐丽 | 2017-11-24 | — | — | CN | disclosed |
| CN-107249735-A | Carbon supported catalyst comprising modifying agent and the method for preparing carbon supported catalyst | 巴斯夫欧洲公司 | 2017-10-13 | — | — | CN | disclosed |
| CN-105367590-B | Biphenyl backbone chiral amino phenol epoxide double-core zinc, magnesium compound and its preparation method and application | 华东理工大学 | 2017-07-21 | — | — | CN | disclosed |
| CN-104968496-B | Possesses the product of the packaging material comprising multilayer structure making | 株式会社可乐丽 | 2017-06-27 | — | — | CN | disclosed |
| US-9636383-B2 | Synthetic platelets | CASE WESTERN RESERVE UNIVERSITY (US) | 2017-05-02 | — | — | US | disclosed |
| EP-3133061-A1 | FLORFENICOL SYNTHESIZING METHOD | Masteam Bio-tech Co. Ltd. (CN) | 2017-02-22 | — | — | EP | disclosed |
| CN-103476966-B | Electroless plating base agent comprising hyperbranched polymer and metal microparticles | 日产化学工业株式会社 | 2016-12-28 | — | — | CN | disclosed |
| US-20160346327-A1 | Synthetic Platelets | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2016-12-01 | — | — | US | disclosed |
| WO-2016188506-A1 | SOLID FORMS OF 5-FLUORO-3-PHENYL-2-[(1S)-1-(9H-PURIN-6-YLAMINO)PROPYL]QUINAZOLIN-4-ONE AND PREPARATION THEREOF | ZENTIVA, K.S. (CZ) | 2016-12-01 | — | — | WO | disclosed |
| US-20160318859-A1 | FLORFENICOL SYNTHESIZING METHOD | MASTEAM BIO-TECH CO. LTD. | 2016-11-03 | — | — | US | disclosed |
| EP-2611818-B1 | PHOSPHONATE ESTER DERIVATIVES AND METHODS OF SYNTHESIS THEREOF | CHIMERIX INC (US) | 2016-08-24 | — | — | EP | disclosed |
| CN-104230725-B | A kind of amido phenols part magnesium, zinc complex and its preparation method and application | 华东理工大学 | 2016-07-06 | — | — | CN | disclosed |
| CN-103864659-B | Chiral imines phenol oxygen base zinc, magnesium compound and its preparation method and application | 华东理工大学 | 2016-06-29 | — | — | CN | disclosed |
| CN-102917536-B | With the metal forming of adhesion auxiliary material and the printing distributing board using it | 日立化成株式会社 | 2016-06-22 | — | — | CN | disclosed |
| CN-103787943-B | Chiral amino phenol oxygen base zinc, magnesium compound and its preparation method and application | 华东理工大学 | 2016-06-15 | — | — | CN | disclosed |
| EP-3020720-A1 | PHOSPHONATE ESTER DERIVATIVES AND METHODS OF SYNTHESIS THEREOF | Chimerix, Inc. (US) | 2016-05-18 | — | — | EP | disclosed |
| US-9303051-B2 | Phosphonate ester derivatives and methods of synthesis thereof | CHIMERIX INC. (US) | 2016-04-05 | — | — | US | disclosed |
| US-9296745-B2 | Diacylglycerol acyltransferase 2 inhibitors | PFIZER INC. (US) | 2016-03-29 | — | — | US | disclosed |
| US-9255096-B1 | Substituted 1,2,3,4-tetrahydrobenzo[C][2,7] naphthyridines and derivatives thereof as kinase inhibitors | ALLERGAN, INC. (US) | 2016-02-09 | — | — | US | disclosed |
| EP-2961521-A1 | ASYMMETRICALLY POROUS MEMBRANES MADE OF CROSS-LINKED THERMOPLASTIC SILICONE ELASTOMER | Wacker Chemie AG (DE) | 2016-01-06 | — | — | EP | disclosed |
| US-20150335717-A1 | SYNTHETIC PLATELETS | CASE WESTERN RESERVE UNIVERSITY | 2015-11-26 | — | — | US | disclosed |
| US-20150329575-A1 | PHOSPHONATE ESTER DERIVATIVES AND METHODS OF SYNTHESIS THEREOF | EMERGENT BIODEFENSE OPERATIONS LANSING LLC | 2015-11-19 | — | — | US | disclosed |
| US-9107845-B2 | Synthetic platelets | CASE WESTERN RESERVE UNIVERSITY (US) | 2015-08-18 | — | — | US | disclosed |
| WO-2015117158-A1 | SYNTHETIC PLATELETS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-08-06 | — | — | WO | disclosed |
| US-9089836-B2 | Porous inorganic/organic hybrid monolith materials for chromatographic separations and process for their preparation | WATERS TECHNOLOGIES CORPORATION (US) | 2015-07-28 | — | — | US | disclosed |
| CN-103610640-B | Alprostadil medium-and-long-chain lipid emulsion for injection and preparation method thereof | UNIV JILIN | 2015-04-15 | — | — | CN | disclosed |
| US-20150087585-A1 | DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS | PFIZER INC. (US) | 2015-03-26 | — | — | US | disclosed |
| WO-2015003880-A1 | ASYMMETRICALLY POROUS MEMBRANES MADE OF ALDEHYDE-CROSSLINKED THERMOPLASTIC SILICONE ELASTOMER | WACKER CHEMIE AG (DE) | 2015-01-15 | — | — | WO | disclosed |
| CN-102690204-B | Method for preparing cyclohexanediamine | DALIAN INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES (CN) | 2014-10-08 | — | — | CN | disclosed |
| WO-2014131673-A1 | ASYMMETRICALLY POROUS MEMBRANES MADE OF CROSS-LINKED THERMOPLASTIC SILICONE ELASTOMER | WACKER CHEMIE AG (DE) | 2014-09-04 | — | — | WO | disclosed |
| US-8729260-B2 | Process for the preparation of carbapenem using cabapenem intermediates and recovery of cabapenem | SAVIOR LIFETEC CORPORATION (TW) | 2014-05-20 | — | — | US | disclosed |
| US-20140099359-A1 | SYNTHETIC PLATELETS | CASE WESTERN RESERVE UNIVERSITY (US) | 2014-04-10 | — | — | US | disclosed |
| CN-103610640-A | Alprostadil medium-and-long-chain lipid emulsion for injection and preparation method thereof | UNIV JILIN | 2014-03-05 | — | — | CN | disclosed |
| US-20140046085-A1 | Phosphonate Ester Derivatives and Methods of Synthesis Thereof | CHIMERIX, INC. (US) | 2014-02-13 | — | — | US | disclosed |
| US-20130324395-A1 | POROUS INORGANIC/ORGANIC HYBRID MONOLITH MATERIALS FOR CHROMATOGRAPHIC SEPARATIONS AND PROCESS FOR THEIR PREPARATION | WATERS TECHNOLOGIES CORPORATION (US) | 2013-12-05 | — | — | US | disclosed |
| US-8569321-B2 | Phosphonate ester derivatives and methods of synthesis thereof | CHIMERIX, INC. (US) | 2013-10-29 | — | — | US | disclosed |
| US-8530654-B2 | Crystals, amorphous substances or salts of methyl N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl) phenyl] terephthalamic acid | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2013-09-10 | — | — | US | disclosed |
| CN-101861367-B | Ink composition | SEIKO EPSON CORP | 2013-08-28 | — | — | CN | disclosed |
| US-8513269-B2 | Preparation for external use | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2013-08-20 | — | — | US | disclosed |
| US-8404346-B2 | Porous inorganic/organic hybrid monolith materials for chromatographic separations and process for their preparation | WATERS TECHNOLOGIES CORPORATION (US) | 2013-03-26 | — | — | US | disclosed |
| US-8299286-B2 | Source reagent compositions and method for forming metal films on a substrate by chemical vapor deposition | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2012-10-30 | — | — | US | disclosed |
| WO-2012142362-A2 | SYNTHETIC PLATELETS | CASE WESTERN RESERVE UNIVERSITY (US) | 2012-10-18 | — | — | WO | disclosed |
| CN-102690204-A | Method for preparing cyclohexanediamine | DALIAN CHEMICAL PHYSICS INST | 2012-09-26 | — | — | CN | disclosed |
| US-8178543-B2 | growth factor receptor tyrosine kinase inhibitor; anticarcinogenic agents; N-{2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-3-hydroxy-3-methylbutanamide | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-05-15 | — | — | US | disclosed |
| EP-2202229-B1 | NOVEL PREPARATION FOR EXTERNAL USE | EISAI R&D MAN CO LTD (JP) | 2012-03-14 | — | — | EP | disclosed |
| US-20120058976-A1 | Phosphonate Ester Derivatives and Methods of Synthesis Thereof | CHIMERIX, INC. (US) | 2012-03-08 | — | — | US | disclosed |
| EP-2315626-B1 | POROUS MEMBRANES MADE UP OF ORGANOPOLYSILOXANE COPOLYMERS | WACKER CHEMIE AG (DE) | 2012-02-22 | — | — | EP | disclosed |
| US-8106073-B2 | Quinoline derivatives 057 | ASTRAZENECA AB (SE) | 2012-01-31 | — | — | US | disclosed |
| US-20110288290-A1 | PROCESS FOR THE PREPARATION OF CARBAPENEM USING CABAPENEM INTERMEDIATES AND RECOVERY OF CABAPENEM | SAVIOR LIFETEC CORPORATION (TW) | 2011-11-24 | — | — | US | disclosed |
| US-20110288289-A1 | Preparation of Carbapenem Intermediate and Their Use | SAVIOR LIFETEC CORPORATION (TW) | 2011-11-24 | — | — | US | disclosed |
| EP-2388261-A2 | Improved process for the preparation of carbapenem using carbapenem intermediates and recovery of carbapenem | Savior Lifetec Corporation (TW) | 2011-11-23 | — | — | EP | disclosed |
| US-D647009-S1 | Motor vehicle and/or toy replica thereof | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2011-10-18 | — | — | US | disclosed |
| EP-2225222-B1 | A QUINOLINE DERIVATIVE ACTING AS A P2X7-RECEPTOR ANTAGONIST | ASTRAZENECA AB (SE) | 2011-09-14 | — | — | EP | disclosed |
| EP-1992622-B1 | 4-(3-BENZOYLAMINOPHENYL)-6,7-DIMETHOXY-2- METHYLAMINOQUINAZOLINE DERIVATIVE | EISAI R&D MAN CO LTD (JP) | 2011-07-27 | — | — | EP | disclosed |
| US-20110175939-A1 | DISPLAY DEVICE | FUJI XEROX CO., LTD. (JP) | 2011-07-21 | — | — | US | disclosed |
| US-20110171382-A1 | SOURCE REAGENT COMPOSITIONS AND METHOD FOR FORMING METAL FILMS ON A SUBSTRATE BY CHEMICAL VAPOR DEPOSITION | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2011-07-14 | — | — | US | disclosed |
| US-7939540-B2 | 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2011-05-10 | — | — | US | disclosed |
| EP-2315626-A1 | POROUS MEMBRANES MADE UP OF ORGANOPOLYSILOXANE COPOLYMERS | Wacker Chemie AG (DE) | 2011-05-04 | — | — | EP | disclosed |
| US-20110021545-A1 | NOVEL PREPARATION FOR EXTERNAL USE | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2011-01-27 | — | — | US | disclosed |
| CN-101861367-A | Ink composition | SEIKO EPSON CORP | 2010-10-13 | — | — | CN | disclosed |
| US-20100227948-A1 | INK COMPOSITION FOR INKJET RECORDING | SEIKO EPSON CORPORATION. | 2010-09-09 | — | — | US | disclosed |
| US-20100222498-A1 | INK COMPOSITION | SEIKO EPSON CORPORATION (JP) | 2010-09-02 | — | — | US | disclosed |
| US-20100216788-A1 | FUSED HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-08-26 | — | — | US | disclosed |
| EP-2213707-A1 | INK COMPOSITION | Seiko Epson Corporation (JP) | 2010-08-04 | — | — | EP | disclosed |
| EP-1686111-B1 | Process for the preparation of 1,1,1,3,3-pentafluoropropane | ALLIED SIGNAL INC (US) | 2010-07-28 | — | — | EP | disclosed |
| EP-2202229-A1 | NOVEL PREPARATION FOR EXTERNAL USE | Eisai R&D Management Co., Ltd. (JP) | 2010-06-30 | — | — | EP | disclosed |
| WO-2010036910-A1 | HEART PROTECTION BY ADMINISTERING AN AMP-ACTIVATED PROTEIN KINASE ACTIVATOR | OHTA YOSHIKAZU (JP) | 2010-04-01 | — | — | WO | disclosed |
| WO-2010036917-A1 | PREVENTION AND TREATMENT OF CANCER WITH RAS GENE MUTATION | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-04-01 | — | — | WO | disclosed |
| WO-2010036928-A1 | PREVENTION AND TREATMENT OF CANCER WITH LKB1 NON-EXPRESSION (DELETION OR MUTATION) | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-04-01 | — | — | WO | disclosed |
| WO-2010020584-A1 | POROUS MEMBRANES MADE UP OF ORGANOPOLYSILOXANE COPOLYMERS | WACKER CHEMIE AG (DE) | 2010-02-25 | — | — | WO | disclosed |
| EP-2123641-A1 | CRYSTAL, AMORPHOUS FORM AND SALT OF METHYL N-Ý3-(6,7-DIMETHOXY- 2-METHYLAMINOQUINAZOLIN-4-YL)PHENYL¨TEREPHTHALAMIC ACID | Eisai R&D Management Co., Ltd. (JP) | 2009-11-25 | — | — | EP | disclosed |
| EP-2007753-B1 | HETEROCYCLIC GABA ALPHA SUBTYPE SELECTIVE RECEPTOR MODULATORS | HOFFMANN LA ROCHE (CH) | 2009-11-11 | — | — | EP | disclosed |
| US-20090203717-A1 | FUSED HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-08-13 | — | — | US | disclosed |
| US-7507740-B2 | Fused heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-03-24 | — | — | US | disclosed |
| US-20090062539-A1 | CRYSTALS, AMORPHOUS SUBSTANCES OR SALTS OF METHYL N-[3-(6,7-DIMETHOXY-2-METHYLAMINOQUINAZOLIN-4-YL) PHENYL] TEREPHTHALAMIC ACID | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2009-03-05 | — | — | US | disclosed |
| US-20090029973-A1 | FUSED HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-01-29 | — | — | US | disclosed |
| US-20090018335-A1 | FUSED HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-01-15 | — | — | US | disclosed |
| EP-2007753-A1 | HETEROCYCLIC GABA ALPHA SUBTYPE SELECTIVE RECEPTOR MODULATORS | F. Hoffmann-Roche AG (CH) | 2008-12-31 | — | — | EP | disclosed |
| EP-1992622-A1 | 4-(3-BENZOYLAMINOPHENYL)-6,7-DIMETHOXY-2- METHYLAMINOQUINAZOLINE DERIVATIVE | Eisai R&D Management Co., Ltd. (JP) | 2008-11-19 | — | — | EP | disclosed |
| EP-1957495-A1 | FUSED HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2008-08-20 | — | — | EP | disclosed |
| US-7323581-B1 | Source reagent compositions and method for forming metal films on a substrate by chemical vapor deposition | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2008-01-29 | — | — | US | disclosed |
| US-20070299094-A1 | 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives | EISAI R&D MANAGEMENT CO., LTD. | 2007-12-27 | — | — | US | disclosed |
| WO-2007115966-A1 | HETEROCYCLIC GABA ALPHA SUBTYPE SELECTIVE RECEPTOR MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-10-18 | — | — | WO | disclosed |
| US-20070244132-A1 | Fused Heterocyclic Compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-10-18 | — | — | US | disclosed |
| US-20070238765-A1 | Heterocyclic GABAA subtype selective receptor modulators | ROCHE PALO ALTO LLC | 2007-10-11 | — | — | US | disclosed |
| US-7250214-B2 | Porous inorganic/organic hybrid monolith materials for chromatographic separations and process for their preparation | WATERS INVESTMENTS LIMITED (US) | 2007-07-31 | — | — | US | disclosed |
| US-20070161803-A1 | Method of asymmetrically reducing 4-[5-(imidazol-1-yl)-2-methylbenzoyl]-3,5- dimethylbenzoic acid or ester thereof | MITSUBISHI PHARMA CORPORATION (JP) | 2007-07-12 | — | — | US | disclosed |
| US-20070135304-A1 | Porous inorganic/organic hybrid monolith materials for chromatographic separations and process for their preparation | WATERS INVESTMENTS LIMITED (US) | 2007-06-14 | — | — | US | disclosed |
| WO-2007064045-A1 | FUSED HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-06-07 | — | — | WO | disclosed |
| EP-1626950-A4 | SERTRALINE COMPOSITIONS | TRANSFORM PHARMACEUTICALS INC (US) | 2007-05-23 | — | — | EP | disclosed |
| US-7208261-B2 | Polymers, processes for polymer synthesis and photoresist compositions | SHIPLEY COMPANY, L.L.C. (US) | 2007-04-24 | — | — | US | disclosed |
| US-7186863-B2 | Sertraline compositions | TRANSFORM PHARMACEUTICALS, INC. (US) | 2007-03-06 | — | — | US | disclosed |
| CN-1922153-A | Method of asymmetrically reducing 4-[5-(imidazol-1-yl)-2-methylbenzoyl]-3,5-dimethylbenzoic acid or ester thereof | MITSUBISHI PHARMA CORP (JP) | 2007-02-28 | — | — | CN | disclosed |
| EP-1752457-A1 | FUSED HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2007-02-14 | — | — | EP | disclosed |
| EP-1719764-A1 | METHOD OF ASYMMETRICALLY REDUCING 4- 5-(IMIDAZOL-1-YL)-2-MET HYLBENZOYL -3,5-DIMETHYL-BENZOIC ACID OR ESTER THEREOF | Mitsubishi Pharma Corporation (JP) | 2006-11-08 | — | — | EP | disclosed |
| EP-1686111-A1 | Process for the preparation of 1,1,1,3,3-pentafluoropropane | AlliedSignal Inc. (US) | 2006-08-02 | — | — | EP | disclosed |
| EP-1070034-B1 | PROCESS FOR THE PREPARATION OF 1-CHLORO-1,1,3,3,3-PENTAFLUOROPROPANE | ALLIED SIGNAL INC (US) | 2006-08-02 | — | — | EP | disclosed |
| EP-1626950-A1 | SERTRALINE COMPOSITIONS | Transform Pharmaceuticals, Inc. (US) | 2006-02-22 | — | — | EP | disclosed |
| US-20050014829-A1 | Sertraline compositions | TRANSFORM PHARMACEUTICALS, INC. | 2005-01-20 | — | — | US | disclosed |
| US-6841331-B2 | Polymers, processes for polymer synthesis and photoresist compositions | SHIPLEY COMPANY, L.L.C. (US) | 2005-01-11 | — | — | US | disclosed |
| WO-2005000786-A1 | SERTRALINE COMPOSITIONS | TRANSFORM PHARMACEUTICALS, INC. (US) | 2005-01-06 | — | — | WO | disclosed |
| US-20040259025-A1 | Novel polymers, processes for polymer synthesis and photoresist compositions | SHIPLEY COMPANY, L.L.C. (US) | 2004-12-23 | — | — | US | disclosed |
| EP-1283672-B1 | ANTITUBULIN ASSEMBLY AND CELL GROWTH INHIBITOR DENOMINATED \"DIOXOSTATIN\ | UNIV ARIZONA STATE (US) | 2004-11-17 | — | — | EP | disclosed |
| EP-1432777-A1 | FLUORESCENT DIKETOPYRROLOPYRROLE ANALOGUES | Ciba SC Holding AG (CH) | 2004-06-30 | — | — | EP | disclosed |
| US-20040122083-A1 | Antitubulin assembly and cell growth inhibitor denominated \"dioxostatin\ | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY | 2004-06-24 | — | — | US | disclosed |
| EP-1313744-A4 | SOURCE REAGENT COMPOSITIONS AND METHOD FOR FORMING METAL FILMS ON A SUBSTRATE BY CHEMICAL VAPOR DEPOSITION | ADVANCED TECH MATERIALS (US) | 2004-03-31 | — | — | EP | disclosed |
| US-20030150811-A1 | Porous inorganic/organic hybrid monolith materials for chromatographic separations and process for their preparation | WATERS INVESTMENTS LIMITED (US) | 2003-08-14 | — | — | US | disclosed |
| EP-1313744-A1 | SOURCE REAGENT COMPOSITIONS AND METHOD FOR FORMING METAL FILMS ON A SUBSTRATE BY CHEMICAL VAPOR DEPOSITION | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2003-05-28 | — | — | EP | disclosed |
| WO-2003014255-A1 | FLUORESCENT DIKETOPYRROLOPYRROLE ANALOGUES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-02-20 | — | — | WO | disclosed |
| EP-1283672-A1 | ANTITUBULIN ASSEMBLY AND CELL GROWTH INHIBITOR DENOMINATED \"DIOXOSTATIN\ | Arizona Board of Regents, acting for and on behalf of Arizona State University (US) | 2003-02-19 | — | — | EP | disclosed |
| US-20030027075-A1 | Novel polymers, processes for polymer synthesis and photoresist compositions | SHIPLEY COMPANY, L.L.C. | 2003-02-06 | — | — | US | disclosed |
| WO-2002018394-A1 | SOURCE REAGENT COMPOSITIONS AND METHOD FOR FORMING METAL FILMS ON A SUBSTRATE BY CHEMICAL VAPOR DEPOSITION | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2002-03-07 | — | — | WO | disclosed |
| EP-0854931-A4 | COILED-COIL HETERODIMER METHODS AND COMPOSITIONS FOR THE DETECTION AND PURIFICATION OF EXPRESSED PROTEINS | PENCE INC (CA) | 2002-02-13 | — | — | EP | disclosed |
| CN-1332229-A | High-energy smoke-eliminating fuel-saving cleaner for diesel oil and gasoline | WANG BAOHANG (CN) | 2002-01-23 | — | — | CN | disclosed |
| WO-2001084929-A1 | ANTITUBULIN ASSEMBLY AND CELL GROWTH INHIBITOR DENOMINATED 'DIOXOSTATIN' | ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2001-11-15 | — | — | WO | disclosed |
| EP-0788498-B1 | PHENYLOXAZOLIDINONE ANTIMICROBIALS | UPJOHN CO (US) | 2001-08-16 | — | — | EP | disclosed |
| US-6187976-B1 | Process for the preparation of fluorine containing hydrohalocarbons | ALLIEDSIGNAL INC. | 2001-02-13 | — | — | US | disclosed |
| EP-1071420-A1 | INDOLYL-3-GLYOXYLIC ACID DERIVATIVES WITH ANTITUMORAL ACTIVITY | ASTA Medica Aktiengesellschaft (DE) | 2001-01-31 | — | — | EP | disclosed |
| EP-1070034-A1 | PROCESS FOR THE PREPARATION OF 1-CHLORO-1,1,3,3,3-PENTAFLUOROPROPANE | Alliedsignal, Inc. (US) | 2001-01-24 | — | — | EP | disclosed |
| EP-1060179-A1 | SUBSTITUTED AMINOMETHYL ISOXAZOLINE DERIVATIVES USEFUL AS ANTIMICROBIALS | PHARMACIA & UPJOHN COMPANY (US) | 2000-12-20 | — | — | EP | disclosed |
| US-6126996-A | Metal complex source reagents for chemical vapor deposition | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2000-10-03 | — | — | US | disclosed |
| US-6110529-A | USING A METALORGANIC REAGENT SOLUTION CONSISTING A METALORGANIC COMPLEX DISSOLVED IN A SOLVENT OR SUSPENDING AGENT TO DEPOSIT A METAL, A METAL OXIDE OR A METAL SULFIDE | ATMI, INC. | 2000-08-29 | — | — | US | disclosed |
| WO-2000013690-A1 | EXOCYCLIC-PHOSPHOETHANOLAMINES | CLARION PHARMACEUTICALS, INC. (US) | 2000-03-16 | — | — | WO | disclosed |
| EP-0873343-A4 | METAL COMPLEX SOURCE REAGENTS FOR CHEMICAL VAPOR DEPOSITION | ADVANCED TECH MATERIALS (US) | 1999-12-15 | — | — | EP | disclosed |
| WO-1999052844-A1 | PROCESS FOR THE PREPARATION OF 1-CHLORO-1,1,3,3,3-PENTAFLUOROPROPANE | ALLIEDSIGNAL, INC. (US) | 1999-10-21 | — | — | WO | disclosed |
| WO-1999051224-A1 | INDOLYL-3-GLYOXYLIC ACID DERIVATIVES WITH ANTITUMORAL ACTIVITY | ASTA MEDICA AKTIENGESELLSCHAFT (DE) | 1999-10-14 | — | — | WO | disclosed |
| EP-0946672-A1 | LIQUID CRYSTAL MATERIALS | SAMSUNG DISPLAY DEVICES CO., LTD. (KR) | 1999-10-06 | — | — | EP | disclosed |
| WO-1999043671-A1 | SUBSTITUTED AMINOMETHYL ISOXAZOLINE DERIVATIVES USEFUL AS ANTIMICROBIALS | PHARMACIA & UPJOHN COMPANY (US) | 1999-09-02 | — | — | WO | disclosed |
| EP-0934940-A1 | CYTOKINE PRODUCTION INHIBITORS, TRIAZEPINE COMPOUNDS, AND INTERMEDIATES THEREOF | Japan Tobacco Inc. (JP) | 1999-08-11 | — | — | EP | disclosed |
| US-5883093-A | TREATING MICROBIAL INFECTIONS IN WARM BLOODED ANIMALS, INCLUDING HUMANS | PHARMACIA & UPJOHN COMPANY (US) | 1999-03-16 | — | — | US | disclosed |
| US-5840897-A | Metal complex source reagents for chemical vapor deposition | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 1998-11-24 | — | — | US | disclosed |
| EP-0717728-B1 | PROCESS FOR THE PREPARATION OF 1,1,1,3,3-PENTAFLUOROPROPANE | ALLIED SIGNAL INC (US) | 1998-11-04 | — | — | EP | disclosed |
| EP-0873343-A1 | METAL COMPLEX SOURCE REAGENTS FOR CHEMICAL VAPOR DEPOSITION | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 1998-10-28 | — | — | EP | disclosed |
| US-5820664-A | METAL COORDINATION COMPLEX, SOLVENT | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 1998-10-13 | — | — | US | disclosed |
| US-5804569-A | ANTIINFLAMMATORY, ANTIARRHYMIC AND LOCAL ANESTHETIC AGENT | CLARION PHARMACEUTICALS INC. (US) | 1998-09-08 | — | — | US | disclosed |
| EP-0854931-A1 | COILED-COIL HETERODIMER METHODS AND COMPOSITIONS FOR THE DETECTION AND PURIFICATION OF EXPRESSED PROTEINS | Pence (CA) | 1998-07-29 | — | — | EP | disclosed |
| US-5780691-A | Process for producing 1,1,1,2,3,3,3,-heptafluoroprane | ALLIED SIGNAL INC. (US) | 1998-07-14 | — | — | US | disclosed |
| WO-1998028247-A1 | PROCESS FOR PRODUCING 1,1,1,2,3,3,3-HEPTAFLUOROPROPANE | ALLIEDSIGNAL INC. (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998011173-A1 | LIQUID CRYSTAL MATERIALS | SAMSUNG DISPLAY DEVICES CO., LTD. (KR) | 1998-03-19 | — | — | WO | disclosed |
| US-5728706-A | ENDOTHELIN ANTAGONISTS | TANABE SEIYAKU CO., LTD. (JP) | 1998-03-17 | — | — | US | disclosed |
| US-5728904-A | Process for the preparation of 1,1,1,3,3-pentafluoropropane | ALLIEDSIGNAL INC. (US) | 1998-03-17 | — | — | US | disclosed |
| EP-0658548-B1 | Benzenesulfonamide derivative and process for preparing thereof | TANABE SEIYAKU CO (JP) | 1997-11-19 | — | — | EP | disclosed |
| EP-0788498-A1 | PHENYLOXAZOLIDINONE ANTIMICROBIALS | PHARMACIA & UPJOHN COMPANY (US) | 1997-08-13 | — | — | EP | disclosed |
| WO-1997012988-A1 | COILED-COIL HETERODIMER METHODS AND COMPOSITIONS FOR THE DETECTION AND PURIFICATION OF EXPRESSED PROTEINS | PENCE (CA) | 1997-04-10 | — | — | WO | disclosed |
| US-5618830-A | TREATING INFLUENZA, PREVENTING INFECTION BY INFLUENZA VIRUS | MERCK & CO., INC. (US) | 1997-04-08 | — | — | US | disclosed |
| EP-0395244-B1 | Pyridine derivatives | WYETH JOHN & BROTHER LTD (GB) | 1997-02-19 | — | — | EP | disclosed |
| US-5589478-A | ENDOTHELIN ANTAGONISTS | TANABE SEIYAKU CO., LTD. (JP) | 1996-12-31 | — | — | US | disclosed |
| WO-1996040690-A1 | METAL COMPLEX SOURCE REAGENTS FOR CHEMICAL VAPOR DEPOSITION | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| EP-0717728-A1 | PROCESS FOR THE PREPARATION OF 1,1,1,3,3-PENTAFLUOROPROPANE | AlliedSignal Inc. (US) | 1996-06-26 | — | — | EP | disclosed |
| EP-0711266-A1 | PROCESS FOR THE PREPARATION OF HYDROFLUOROCARBONS HAVING 3 TO 7 CARBON ATOMS | AlliedSignal Inc. (US) | 1996-05-15 | — | — | EP | disclosed |
| WO-1996013502-A1 | PHENYLOXAZOLIDINONE ANTIMICROBIALS | PHARMACIA & UPJOHN COMPANY (US) | 1996-05-09 | — | — | WO | disclosed |
| EP-0296852-B1 | Method of making purely primary diamines | MINNESOTA MINING & MFG (US) | 1996-03-06 | — | — | EP | disclosed |
| WO-1996006073-A1 | LIQUID CRYSTAL MATERIALS | WOJSKOWA AKADEMIA TECHNICZNA (PL) | 1996-02-29 | — | — | WO | disclosed |
| EP-0486029-B1 | Photographic elements containing release compounds-II | EASTMAN KODAK CO (US) | 1996-01-24 | — | — | EP | disclosed |
| US-5475109-A | Useful in prevention or treatment of infection by influenza virus | MERCK & CO., INC. (US) | 1995-12-12 | — | — | US | disclosed |
| US-5431957-A | Apparatus and method for protection of pumps used for delivery of air- or moisture-sensitive liquids | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 1995-07-11 | — | — | US | disclosed |
| EP-0658548-A1 | Benzenesulfonamide derivative and process for preparing thereof | TANABE SEIYAKU CO., LTD. (JP) | 1995-06-21 | — | — | EP | disclosed |
| US-5395997-A | Process for the preparation of hydrofluorocarbons having 3 to 7 carbon atoms | ALLIEDSIGNAL INC. (US) | 1995-03-07 | — | — | US | disclosed |
| WO-1995004022-A1 | PROCESS FOR THE PREPARATION OF 1,1,1,3,3-PENTAFLUOROPROPANE | ALLIEDSIGNAL INC. (US) | 1995-02-09 | — | — | WO | disclosed |
| WO-1995004021-A1 | PROCESS FOR THE PREPARATION OF HYDROFLUOROCARBONS HAVING 3 TO 7 CARBON ATOMS | ALLIEDSIGNAL INC. (US) | 1995-02-09 | — | — | WO | disclosed |
| US-5254439-A | Light-sensitive polymer, method for preparing the same and method for forming patterns | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1993-10-19 | — | — | US | disclosed |
| US-5220042-A | Antiasthmatics, antiallergens, cardiovasculsr disorders | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-06-15 | — | — | US | disclosed |
| US-5194439-A | 5-HT Agonists or Antagonists, Nervous System Disorders, Hypotensive Agents | JOHN WYETH & BROTHER LIMITED (GB) | 1993-03-16 | — | — | US | disclosed |
| EP-0151995-B1 | NOVEL 1,4-BENZOQUINONE DERIVATIVES AND BENZENE DERIVATIVES, AND PROCESS FOR PREPARING THE SAME | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-12-23 | — | — | EP | disclosed |
| US-5126419-A | Light-sensitive polymer, method for preparing the same andmethod for forming patterns | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1992-06-30 | — | — | US | disclosed |
| US-5124334-A | Antiinflammatory agents, antiallergens | DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1992-06-23 | — | — | US | disclosed |
| EP-0215622-B1 | NAPHTHALENE ANTI-PSORIATIC AGENTS AND PROCESS FOR MAKING THEM | SYNTEX (U.S.A.) INC. (US) | 1992-06-17 | — | — | EP | disclosed |
| EP-0486029-A1 | Photographic elements containing release compounds-II | EASTMAN KODAK COMPANY (US) | 1992-05-20 | — | — | EP | disclosed |
| US-5075303-A | Central nervous system disorders | JOHN WYETH & BROTHER LIMITED (GB) | 1991-12-24 | — | — | US | disclosed |
| US-5055385-A | Rapid release from timing group | EASTMAN KODAK COMPANY (US) | 1991-10-08 | — | — | US | disclosed |
| EP-0158826-B1 | ELECTROEROSION RECORDING MATERIALS WITH NEW HYDROPHILIC PROTECTIVE COATING | International Business Machines Corporation (US) | 1991-07-24 | — | — | EP | disclosed |
| EP-0328585-A4 | METABOLICALLY ACCEPTABLE POLYISOCYANATE ADHESIVES | — | 1991-06-05 | — | — | EP | disclosed |
| EP-0402932-A1 | Photopolymerizable coating products | OECE Industrie Chimiche Spa (IT) | 1990-12-19 | — | — | EP | disclosed |
| EP-0395244-A1 | Pyridine derivatives | JOHN WYETH & BROTHER LIMITED (GB) | 1990-10-31 | — | — | EP | disclosed |
| US-4948800-A | MUSCLE RELAXANTS; ANTICONVULSANTS; ANXIOLYTIC AGENTS; 3-HYDROXYALKYL-PYRIDO(4,5-B OR-C)IMIDAZOLE COMPOUNDS | A. H. ROBINS COMPANY, INCORPORATED (US) | 1990-08-14 | — | — | US | disclosed |
| US-4946845-A | STABLE ANTIINFLAMMATORY AGENTS, LIPOXYGENASE INHIBITORS | SYNTEX (U.S.A.) INC. (US) | 1990-08-07 | — | — | US | disclosed |
| US-4933396-A | Method of making purely primary diamines | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-06-12 | — | — | US | disclosed |
| US-4914109-A | ANTICONVULSANTS, ANTIANXIETY AGENTS | A. H. ROBINS COMPANY, INCORPORATED (US) | 1990-04-03 | — | — | US | disclosed |
| US-4900772-A | Curable resin composition | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1990-02-13 | — | — | US | disclosed |
| US-4894279-A | Wear resistant layer composed of polymer modified by organotitanium compound | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1990-01-16 | — | — | US | disclosed |
| US-4873251-A | MUSCLE RELAXANTS, ANTICONVULSANTS, ANTIANXIETY AGENTS | A. H. ROBINS COMPANY, INCORPORATED (US) | 1989-10-10 | — | — | US | disclosed |
| EP-0146145-B1 | NAPHTHALENE ANTI-PSORIATIC AGENTS | SYNTEX (U.S.A.) INC. (US) | 1989-08-30 | — | — | EP | disclosed |
| EP-0328585-A1 | METABOLICALLY ACCEPTABLE POLYISOCYANATE ADHESIVES | BIORESEARCH INC. (US) | 1989-08-23 | — | — | EP | disclosed |
| US-4833213-A | Method of making purely primary diamines from nitrogen containing nocleophile and terminally electrophilically active polyether | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-05-23 | — | — | US | disclosed |
| US-4824951-A | MUSCLE RELAXANTS, ANTICONVULSANTS, ANXIOLYTIC AGENTS | A. H. ROBINS COMPANY, INCORPORATED (US) | 1989-04-25 | — | — | US | disclosed |
| EP-0147642-B1 | ELECTROEROSION PRINT MEDIA HAVING A PROTECTIVE COATING | International Business Machines Corporation (US) | 1989-02-01 | — | — | EP | disclosed |
| WO-1989000589-A1 | METABOLICALLY ACCEPTABLE POLYISOCYANATE ADHESIVES | BIORESEARCH, INC. (US) | 1989-01-26 | — | — | WO | disclosed |
| EP-0296852-A2 | Method of making purely primary diamines | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1988-12-28 | — | — | EP | disclosed |
| US-4792556-A | LIPOXYGENASE INHIBITORS | SYNTEX (U.S.A.) INC. (US) | 1988-12-20 | — | — | US | disclosed |
| US-4772600-A | MUSCLE RELAXANTS, ANTICONVULSANTS, ANXIOLYTIC | A. H. ROBINS COMPANY, INC. (US) | 1988-09-20 | — | — | US | disclosed |
| EP-0255217-A1 | Fused imidazoheterocyclic compounds | A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) (US) | 1988-02-03 | — | — | EP | disclosed |
| EP-0215622-A2 | Naphthalene anti-psoriatic agents and process for making them | SYNTEX (U.S.A.) INC. (US) | 1987-03-25 | — | — | EP | disclosed |
| US-4652560-A | ANTIBIOTICS, BACTERICIDES | BEECHAM GROUP P.L.C. (GB) | 1987-03-24 | — | — | US | disclosed |
| US-4617579-A | Hydrophilic protective coatings for electroerosion printing | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1986-10-14 | — | — | US | disclosed |
| US-4593120-A | Naphthalene-1,4-dicarboxylic acid group | SYNTEX (U.S.A.) INC. (US) | 1986-06-03 | — | — | US | disclosed |
| EP-0107512-B1 | 1,4-ACYLOXYNAPHTHALENE DERIVATIVES, TOPICAL COMPOSITIONS CONTAINING THEM, METHODS FOR THEIR PREPARATION, AND INTERMEDIATES THEREFOR | SYNTEX (U.S.A.) INC. (US) | 1986-02-26 | — | — | EP | disclosed |
| EP-0158826-A2 | Electroerosion recording materials with new hydrophilic protective coating | International Business Machines Corporation (US) | 1985-10-23 | — | — | EP | disclosed |
| US-4539202-A | SYNERGISTIC MIXTURE WITH PENICILLINS | BEECHAM GROUP P.L.C. (GB) | 1985-09-03 | — | — | US | disclosed |
| EP-0151995-A2 | Novel 1,4-benzoquinone derivatives and benzene derivatives, and process for preparing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1985-08-21 | — | — | EP | disclosed |
| EP-0147642-A2 | Electroerosion print media having a protective coating | International Business Machines Corporation (US) | 1985-07-10 | — | — | EP | disclosed |
| EP-0146145-A2 | Naphthalene anti-psoriatic agents | SYNTEX (U.S.A.) INC. (US) | 1985-06-26 | — | — | EP | disclosed |
| US-4466981-A | Naphthalene anti-psoriatic agents | SYNTEX (U.S.A.) INC. (US) | 1984-08-21 | — | — | US | disclosed |
| EP-0111933-A2 | Organopolysiloxanes having Si-C-bound oxyalkylene units, process for preparing them and use of these organopolysiloxanes | Wacker-Chemie GmbH (DE) | 1984-06-27 | — | — | EP | disclosed |
| EP-0107512-A1 | 1,4-Acyloxynaphthalene derivatives, topical compositions containing them, methods for their preparation, and intermediates therefor | SYNTEX (U.S.A.) INC. (US) | 1984-05-02 | — | — | EP | disclosed |
| US-4433158-A | 3-Hydroxyiminoscirpen-4β, 15-diol esters useful as antitumor agents | BRISTOL-MYERS COMPANY (US) | 1984-02-21 | — | — | US | disclosed |
| US-4419368-A | 2,2,3,3-TETRAHYDROXY- | SYNTEX (U.S.A.) INC. (US) | 1983-12-06 | — | — | US | disclosed |
| EP-0077794-A1 | SOLUBLE POLYSILASTYRENE AND METHOD FOR PREPARATION | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1983-05-04 | — | — | EP | disclosed |
| WO-1982003862-A1 | SOLUBLE POLYSILASTYRENE AND METHOD FOR PREPARATION | WISCONSIN ALUMNI RES FOUND (US) | 1982-11-11 | — | — | WO | disclosed |
| EP-0055043-A2 | 6,7,8,9-Tetrahydro-3H-benz(e)indolamine derivatives, processes for their preparation and intermediates used therein, and pharmaceutical compositions containing the indolamine derivatives | AYERST, MCKENNA AND HARRISON INC. (CA) | 1982-06-30 | — | — | EP | disclosed |
| US-4332951-A | Antitumor agents | BRISTOL-MYERS COMPANY (US) | 1982-06-01 | — | — | US | disclosed |
| US-4324901-A | Soluble polysilastyrene and method for preparation | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1982-04-13 | — | — | US | disclosed |
| US-4267113-A | Antitumor agents | BRISTOL-MYERS COMPANY (US) | 1981-05-12 | — | — | US | disclosed |
| US-4191714-A | CONTAINING SILYL GROUP ON SIDE CHAIN OR POLYMER END | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1980-03-04 | — | — | US | disclosed |
| EP-0007041-A1 | Process for the preparation of anthrone | BAYER AG (DE) | 1980-01-23 | — | — | EP | disclosed |
| US-3971751-A | ROOM TEMPERATURE | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JA) | 1976-07-27 | — | — | US | disclosed |
| US-3971751-A | ROOM TEMPERATURE | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JA) | 1976-07-27 | — | — | US | disclosed |